Elijah Nouvelage/Getty Images(NEW YORK) — The Centers for Disease Control and Prevention’s vaccine advisory committee on Friday indefinitely postponed its planned vote on whether to stop recommending the hepatitis B vaccine for newborns. Robert Malone, a panel member and vaccine critic, proposed tabling the vote out of concern that there had not been enough discussion about the safety of the hepatitis B vaccines. It also may be difficult to guess who is at risk and should be tested — half of people living with Hepatitis B don’t know they are infected, according to the CDC. When the U.S. had a risk-based approach to vaccination before 1991, it was estimated that 200,000 to 300,000 new hepatitis B infections occurred annually in the U.S. from 1980 to 1991 and over 1 million people were living with chronic hepatitis B infection, according to the CDC. However, hepatitis B is still a huge problem among adults in the U.S. It’s estimated that up to 2.4 million people in the country are living with chronic hepatitis B, with many being asymptomatic and unaware of their diagnosis, according to the CDC.